Rehm HL. Overcoming Barriers to Genomic Medicine Implementation. Clinical chemistry. 2025;71(1):4-9. doi:10.1093/clinchem/hvae147
Publications
Rehm HL. Overcoming Barriers to Genomic Medicine Implementation. Clinical chemistry. 2025;71(1):4-9. doi:10.1093/clinchem/hvae147
Giersch ABS, Morton CC. Newborn Screening for Deafness/Hard of Hearing in the Genomic Era. Clinical chemistry. 2025;71(1):54-60. doi:10.1093/clinchem/hvae193
Giersch ABS, Morton CC. Newborn Screening for Deafness/Hard of Hearing in the Genomic Era. Clinical chemistry. 2025;71(1):54-60. doi:10.1093/clinchem/hvae193
Adams S, Trocki OM, Miller C, et al. Routine Prenatal cfDNA Screening for Autosomal Dominant Single-Gene Conditions. Clinical chemistry. 2025;71(1):129-140. doi:10.1093/clinchem/hvae189
Adams S, Trocki OM, Miller C, et al. Routine Prenatal cfDNA Screening for Autosomal Dominant Single-Gene Conditions. Clinical chemistry. 2025;71(1):129-140. doi:10.1093/clinchem/hvae189
Raghavan R, Friedrich MJ, King I, et al. Rational engineering of minimally immunogenic nucleases for gene therapy. Nature communications. 2025;16(1):105. doi:10.1038/s41467-024-55522-1
Iorgulescu B, Blewett T, Xiong K, et al. Impact of Higher Cell-Free DNA Yields on Liquid Biopsy Testing in Glioblastoma Patients. Clinical chemistry. 2025;71(1):215-225. doi:10.1093/clinchem/hvae178
Rehm HL. Overcoming Barriers to Genomic Medicine Implementation. Clinical chemistry. 2025;71(1):4-9. doi:10.1093/clinchem/hvae147
Giersch ABS, Morton CC. Newborn Screening for Deafness/Hard of Hearing in the Genomic Era. Clinical chemistry. 2025;71(1):54-60. doi:10.1093/clinchem/hvae193